Biogen shares leap as Alzheimer's drug shows potential to slow disease
July 06, 2018 at 11:14 AM EDT
The company's data analysis marks a rare dose of good news in Alzheimer’s research, a field riddled with high-profile clinical failures.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|